Home » Career
Category Archives: Career
Dr. Wang has been awarded the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Trailblazer Award. This generous support from NIBIB will help Wang Lab to explore new oral drugs to treat inflammatory and infectious diseases using organoid platforms.
Dr. Wang participated in the American Society for Engineering Education (ASEE) 2022 Annual Conference. As the sponsor of ASEE, ISU had various sessions and programs. A lot of fun!
We’re less than one week away from the 2022 SFB Annual Meeting! Join us at the “Biomaterials for Organoids” Session and “Biomaterials for Regenerative Engineering” Session in Baltimore. A lot of great programs and SIG Mixer social. See you then!
New students, Jack Girton and Elijah Vanderkamp will join Wang Lab as Honor Research program researchers to work on organoids reprogramming and cell-mediated drug deliver projects. Chemical Engineering senior Zhao Ren Tan will start his research this Spring on the oral vaccine project. Welcome!
Dr. Wang has been nominated as a member of the Finance Committee for the Controlled Release Society (CRS). The overarching function of this standing committee is to provide advice to the Board on all financial matters, ensuring that the CRS will fulfill its Mission and move towards its aspirational Vision. Dr. Wang has had a long-term relationship with CRS since the 2010 Jorge Heller Postdoctoral Fellow supported by CRS. It’s a great honor to serve CRS, the leading society in the Drug Delivery field.
Tomorrow, Dr. Wang will talk at the 2021 AIChE Annual Meeting in Biotherapeutic Development and Delivery Session. The title is “Gut Organoid As a Platform for Evaluating the Delivery of Nanoparticles to Treat Gastrointestinal Diseases.” Join us to learn about organoids’ latest biotherapeutic technologies at 8:00 AM ET, Thursday, November 18, 2021. The Zoom Access Link: https://meetbreakout.zoom.us/j/92982577004?pwd=Vmt4c1ZKeitZaUZwMHpycUFUTHBxUT09
Dr. Wang will give a talk at Nanovaccines Institute on 4:00 PM Thurs., Oct. 28th, about “Organoid as a New Platform to Develop Oral Vaccines and Nanomedicines.”
Please Join us Thurs., Oct. 28th for our @nanovax Seminar Series!
The Society For Biomaterials is excited to host the 2022 Annual Meeting at the Baltimore Marriott Waterfront April 27-30, 2022, in Baltimore, MD. The “Biomaterials for Organoids” session was well-recognized in the 2021 SFB meeting and is an exciting emerging research area. In 2022, we will continue this session and promote translational research to biomaterials-mediated organoid projects’ commercial viability. You are welcome to submit your abstract at https://2022.biomaterials.org/. See you in Baltimore!
This week, at the 2021 Controlled Release Society Annual Meeting, Dr. Wang did a presentation using gut organoids as a platform for evaluating the delivery of nanoparticles to treat inflammatory bowel disease. The research took advantage of gut organoids as an ex vivo platform to evaluate nanoparticles absorption, distribution, metabolism, and excretion (ADME) screening by gut epithelial cells while focusing on the effect of particle charges. Bioengineered organoids have garnered momentum for their applications in modeling human development and disease, drug screening, and future vaccine design.